- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04464044
Clinical Performance of a Daily Disposable Toric Silicone Hydrogel Contact Lens
August 18, 2020 updated by: Alcon Research
The purpose of this study is to obtain on-eye clinical performance data to evaluate the stability of axis orientation of DDT2 toric contact lenses in the intended population.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This is a single-visit, non-dispense study where subjects will be exposed to the test lenses for approximately 1 hour.
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
Fort Worth, Texas, United States, 76134
- Contact Alcon Call Center for Trial Locations
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Able to understand and sign an informed consent form;
- Successful wear of spherical or toric soft contact lenses in both eyes, as specified in the protocol;
- Willing to NOT use rewetting/lubricating drops at any time during the study;
- Other protocol-specified inclusion criteria may apply.
Exclusion Criteria:
- Any eye condition that would contraindicate contact lens wear, as determined by the Investigator;
- History of eye surgery within the previous 12 months, as specified in the protocol;
- Current or history of dry eye in either eye that, in the opinion of the Investigator, would preclude contact lens wear;
- Other protocol-specified exclusion criteria may apply.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Device Feasibility
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: DDT2 Toric
Verofilcon A toric contact lenses worn in both eyes
|
Daily disposable toric soft contact lenses
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percent of lenses with axis orientation within ±30° from the intended axis, 10 minutes after lens insertion
Time Frame: Day 1, 10 minutes after lens insertion
|
Axis orientation (orientation of the scribe mark) will be assessed by slit lamp examination and recorded as deviations from intended axis.
|
Day 1, 10 minutes after lens insertion
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 20, 2020
Primary Completion (Actual)
August 6, 2020
Study Completion (Actual)
August 6, 2020
Study Registration Dates
First Submitted
July 7, 2020
First Submitted That Met QC Criteria
July 7, 2020
First Posted (Actual)
July 9, 2020
Study Record Updates
Last Update Posted (Actual)
August 19, 2020
Last Update Submitted That Met QC Criteria
August 18, 2020
Last Verified
August 1, 2020
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- CLA306-C003
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Astigmatism
-
Bausch & Lomb IncorporatedNot yet recruiting
-
London Vision ClinicOptana GmbHActive, not recruitingCorneal AstigmatismUnited Kingdom
-
Eye Hospital Pristina KosovoActive, not recruiting
-
Yonsei UniversityUnknownMyopic AstigmatismKorea, Republic of
-
Abbott Medical OpticsCompletedRefractive AstigmatismAustria
-
Ohio State UniversityAlcon ResearchCompletedAstigmatism BilateralUnited States
-
Ohio State UniversityCompletedAstigmatism BilateralUnited States
-
CooperVision, Inc.Completed
-
Cairo UniversityUnknown
Clinical Trials on verofilcon A toric contact lenses
-
Alcon ResearchCompletedRefractive Errors | AstigmatismUnited States
-
Ohio State UniversityCompletedContact LensUnited States
-
Alcon ResearchCompletedAstigmatism | Myopia | AmetropiaUnited States
-
Alcon ResearchTerminatedRefractive ErrorsUnited States
-
Alcon ResearchCompletedRefractive Errors | Astigmatism | AmetropiaUnited States
-
CooperVision, Inc.Completed
-
Alcon ResearchCompleted
-
Alcon ResearchCompletedRefractive ErrorUnited States
-
University of WaterlooAlcon ResearchCompleted
-
Alcon ResearchCompletedRefractive Error | MyopiaUnited States